VitaStem/USDC
VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
Score | 39 |
|---|---|
24h Vol | $37.23 |
Liquidity | $6.3K |
Holders | 1.1K |
Audits | |
Age | 8 months |
FDV | $295.2K |
Market Cap | $94.2K |
| Addresses | |
|---|---|
| Pool | |
| VitaStem |  |
| USDC | |
VitaStem to USDC Converter
Score | 39 |
|---|---|
24h Vol | $37.23 |
Liquidity | $6.3K |
Holders | 1.1K |
Audits | |
Age | 8 months |
FDV | $295.2K |
Market Cap | $94.2K |
About VitaStem (VitaStem)
VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
VitaStem/USDC Price Stats
The current price of VitaStem (VitaStem/USDC) on Uniswap V4 (Base) is $0.02952, the price is up -2.03% in the last 24 hours. Its 24-hour trading volume is reported to be at $37.23 with a total of 6 transactions. VitaStem/USDC contract address is 0x85bc7e64aae1a4d14307300b2c661fd1e387df5f8d2f200a4fab0d04886ddea9, with a Fully Diluted Valuation (FDV) of $295.17K and a liquidity pool of $6,325.82.
